U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
87918791Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular DiseasesRecruitingNo Results AvailableNeovascularization, PathologicDrug: ACM-1https://ClinicalTrials.gov/show/NCT02448732
87928792Single-Dose Phase 1 Study of TAK-792Not yet recruitingNo Results AvailableHealthyDrug: TAK-792 30 mg|Drug: TAK-792 30 mg placebo|Drug: TAK-792 100 mg|Drug: TAK-792 100 mg placebo|Drug: TAK-792 250 mg|Drug: TAK-792 250 mg placebo|Drug: TAK-792 500 mg|Drug: TAK-792 500 mg placebo|Drug: TAK-792 750 mg|Drug: TAK-792 750 mg placebo|Drug: TAK-792 900 mg|Drug: TAK-792 900 mg placebohttps://ClinicalTrials.gov/show/NCT02448719
87938793Variability In Hearing Aid Outcomes In Older AdultsRecruitingNo Results AvailableHearing Loss|PresbycusisDevice: Hearing Aid Fitting A|Device: Hearing Aid Fitting Bhttps://ClinicalTrials.gov/show/NCT02448706
87948794Study of Narrow Band Imaging in the Characterization of Residual Neoplasia After Endoscopic Piecemeal Mucosal ResectionRecruitingNo Results AvailableColorectal NeoplasmsDevice: WLE|Device: NBIhttps://ClinicalTrials.gov/show/NCT02448693
87958795A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients From ≥6 Months Old to - Not yet recruitingNo Results AvailableHemophilia A With Inhibitors|Hemophilia B With InhibitorsBiological: Coagulation FVIIa (Recombinant)https://ClinicalTrials.gov/show/NCT02448680
87968796Energy Supplements to Improve Exercise Tolerance in Metabolic MyopathiesRecruitingNo Results AvailableGlycogen Storage Disease Type IIIDietary Supplement: FAXE Kondi|Dietary Supplement: Faxe Kondi Freehttps://ClinicalTrials.gov/show/NCT02448667
87978797Treatment for Nicotine Addiction in WomenNot yet recruitingNo Results AvailableNicotine DependenceDrug: Tolcapone|Drug: Sugar Pillhttps://ClinicalTrials.gov/show/NCT02448654
87988798Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic StrokeNot yet recruitingNo Results AvailableChronic Ischemic StrokeBiological: SB623 Implant (2.5M)|Biological: SB623 Implant (5.0M)|Procedure: Sham surgeryhttps://ClinicalTrials.gov/show/NCT02448641
87998799A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal ImpairmentRecruitingNo Results AvailableHypertensionDrug: CS-3150https://ClinicalTrials.gov/show/NCT02448628
88008800Birth Cohort in Coast Province, KenyaNot yet recruitingNo Results AvailableMortality|Morbidity|Child Development|Child Behaviourhttps://ClinicalTrials.gov/show/NCT02448615
88018801Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary InsomniaRecruitingNo Results AvailablePrimary InsomniaOther: acupuncture|Other: acupuncture|Other: acupuncturehttps://ClinicalTrials.gov/show/NCT02448602
88028802An Investigation of TAS-119 Monotherapy and in Combination With DocetaxelRecruitingNo Results AvailableAdvanced Solid TumorsDrug: Docetaxel|Drug: TAS-119https://ClinicalTrials.gov/show/NCT02448589
88038803PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line ChemotherapyRecruitingNo Results AvailableBreast Cancer|Brain MetastasisRadiation: prophylactic cranial irradiationhttps://ClinicalTrials.gov/show/NCT02448576
88048804Reducing Obesity in Underserved Postpartum African American WomenCompletedNo Results AvailableObesityBehavioral: Nutrition and physical activity educationhttps://ClinicalTrials.gov/show/NCT02448563
88058805Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization TrialRecruitingNo Results AvailablePercutaneous Coronary InterventionDrug: Bivalirudin|Drug: Unfractionated heparinhttps://ClinicalTrials.gov/show/NCT02448550
88068806A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable SarcomasRecruitingNo Results AvailableMetastatic SarcomaDrug: PM01183|Drug: Doxorubicin|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT02448537
88078807A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) in the Treatment of Patients With Coronary Heart DiseaseRecruitingNo Results AvailableCoronary Heart DiseaseDevice: MiStentTM|Device: TIVOLIhttps://ClinicalTrials.gov/show/NCT02448524
88088808Local Application of Ozone Gas for Infected UlcersCompletedNo Results AvailableUlcer|Wound InfectionOther: Ozone|Device: Placebo|Other: Conventional treatmenthttps://ClinicalTrials.gov/show/NCT02448511
88098809Strength Training Regimen for Normal Weight DiabeticsNot yet recruitingNo Results AvailableDiabetes MellitusBehavioral: Exercise Interventionhttps://ClinicalTrials.gov/show/NCT02448498
88108810High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)CompletedNo Results AvailableAortic Stenosis|Heart Failure|Syncope|Angina PectorisProcedure: Aortic Valve Intervention (surgical or transcatheter)https://ClinicalTrials.gov/show/NCT02448485
88118811Epidemiology of Sepsis in ChinaNot yet recruitingNo Results AvailableSepsisOther: Observational study, none interventionhttps://ClinicalTrials.gov/show/NCT02448472
88128812COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation (COOL-COS) Associated With Corifollitropin Alfa: a Pilot StudyEnrolling by invitationNo Results AvailableInfertilityDrug: COOL-COShttps://ClinicalTrials.gov/show/NCT02448459
88138813The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid ExudatesRecruitingNo Results AvailableDiabetic Macular Edema|Hard Lipid ExudatesDrug: ranibizumab 0.3mghttps://ClinicalTrials.gov/show/NCT02448446
88148814Phototherapy in Young People With DepressionRecruitingNo Results AvailableDepressionDevice: Phototherapy light-emitting glasseshttps://ClinicalTrials.gov/show/NCT02448433
88158815Study of Palbociclib and Trastuzumab With or Without Letrozole in HER2-positive Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Palbociclib|Drug: Trastuzumab|Drug: Letrozolehttps://ClinicalTrials.gov/show/NCT02448420
88168816Intraarticular Injections of Platelet-rich Plasma in Pain's Treatment of the Osteoarthritic KneeCompletedNo Results AvailableKnee OsteoarthritisBiological: Platelet rich plasma|Drug: Hyaluronic acidhttps://ClinicalTrials.gov/show/NCT02448407
88178817Assessment of a Community Support Worker Intervention for PLWH in Rural EthiopiaNot yet recruitingNo Results AvailableHIVOther: Community Support Workerhttps://ClinicalTrials.gov/show/NCT02448394
88188818Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)Not yet recruitingNo Results AvailableCutaneous T-Cell LymphomaDrug: SGX301 (synthetic hypericin)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02448381
88198819RDEA3170 Tablet and Capsule Bioavailability StudyActive, not recruitingNo Results AvailableHealthyDrug: RDEA3170, 5mg|Drug: RDEA3170,10 mg|Drug: RDEA3170, 2.5 mghttps://ClinicalTrials.gov/show/NCT02448368
88208820Ocular Effects of Carotid EndarterectomyNot yet recruitingNo Results AvailableChoroid|Carotid Stenosis|Carotid EndarterectomyDevice: OCT swept source DRI-Atlantis, Topconhttps://ClinicalTrials.gov/show/NCT02448355

* Görseller ve İçerik tekif hakkına sahip olabilir